MarketPulse — Real-Time Financial News & Market Analysis

Nvidia sold its entire 7.7M share stake in Applied Digital during Q4 2025. Despite exit concerns, Applied Digital's 250% revenue growth and AI data center demand suggest underlying strength.

Tactile Medical ($TCMD) appoints veteran healthcare executive Andrea Pearson to board, strengthening governance with 25+ years of industry scaling expertise.

CPI Aerostructures wins $4M Sikorsky contract for MH-60 SEAHAWK helicopter maintenance, demonstrating entrenched position supplying Navy platforms with recurring sustainment revenue.

Keros Therapeutics presented Phase 1 data for rinvatercept showing good tolerability and increased muscle mass, planning Phase 2 trials in DMD and ALS.

eToro reports mixed February metrics: AUA grew 13% YoY to $17.6B, but capital markets trades surged while per-trade values fell 35%. Crypto trading declined 36%.

Sharplink reported full-year 2025 results with 868,699 ETH holdings and surging institutional ownership from 6% to 46%, offset by $734.6M net loss.

$FMFC invests $2.5M for 15% stake in Philippines manufacturer, gaining 477K sq ft capacity and 3,500 employees—first major expansion outside Cambodia.

Controlled Thermal Resources merges with Plum Acquisition Corp. IV in $4.7B deal to develop Hell's Kitchen geothermal and lithium project in California.

Lyell Immunopharma closes $50M funding tranche, advances ronde-cel in pivotal lymphoma trial, appoints new CFO with extended cash runway through Q2 2027.

Adobe becomes official MLB Opening Day sponsor through 2028, deploying enterprise AI tools to enhance fan engagement across the league's digital operations.

Apple deployed $841B in buybacks since 2013, reducing shares 43.3%, but faces slowing device sales growth and 33x earnings valuation, raising questions about financial engineering versus genuine value creation.

BYD targets 35-45% overseas revenue within three years while maintaining low-to-mid teen margins, aiming for Toyota-like operational discipline over explosive growth.

Hims & Hers and Novo Nordisk end legal battle, partnering to distribute weight-loss drugs via telehealth. Stock surges 48.67% despite mixed guidance.

Denison Mines commences 2,500-metre winter drilling at Wheeler North Joint Venture in Saskatchewan, with plans for 7,500 metres in 2026, targeting uranium mineralization zones.

NRx subsidiary HOPE Therapeutics opened a Palm Beach clinic offering same-day ketamine, TMS, and hyperbaric oxygen treatments for depression and PTSD, reporting 87% clinical response rates and 90% functional recovery with combined therapy.

Boundless Bio reported $107.6M cash, narrowed 2025 net losses to $58.2M, and is advancing lead breast cancer candidate BBI-940 through Phase 2 trials.

Editas Medicine reported Q4 2025 net loss of $5.6M, down 88% YoY. Lead CRISPR therapy EDIT-401 shows >90% LDL-C reduction; IND submission expected mid-2026.

Castle Biosciences' DecisionDx-Melanoma test confirmed 2.6% nodal positivity in 912 patients predicted low-risk, supporting safe SLNB avoidance and validating the diagnostic platform.

Kyntra Bio will report fourth quarter and full year 2025 financial results on March 16, 2026, as the biopharmaceutical company advances its oncology and rare disease pipeline.

AOI secures $200M order for advanced data center transceivers from hyperscale customer, ramping production to 500K units monthly by year-end.